F27 (Risedronate Sodium 35 mg)
Pill with imprint F27 is Orange, Round and has been identified as Risedronate Sodium 35 mg. It is supplied by Aurobindo Pharma Limited.
Risedronate is used in the treatment of osteoporosis; paget's disease; prevention of osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Risedronate 35 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for F27
Risedronate Sodium
- Imprint
- F27
- Strength
- 35 mg
- Color
- Orange
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Bisphosphonates
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma Limited
- National Drug Code (NDC)
- 65862-0519
- Inactive Ingredients
-
crospovidone,
hydroxypropyl cellulose,
hypromellose 2910 (5 mPa.s),
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol 400,
titanium dioxide,
silicon dioxide,
ferric oxide red,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related Images for "F27"
More about risedronate
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (63)
- Patient tips
- Drug images
- Pricing & coupons
- En español
- Drug class: bisphosphonates
Patient resources
- Drug Information
- Risedronate (Advanced Reading)
- Risedronate Delayed-Release Tablets
- Risedronate Tablets
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.